Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 16/10/2019
SIETES contiene 92824 citas

<< anterior 21 a 40 de 358 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Watson R. Drug companies may provide information directly to EU patients. BMJ 2010;341:1186. [Ref.ID 89764]
23. Cita con resumen
Petit-Zeman S, Firkins L, Scadding JW. The James Lind Alliance: tackling research mismatches. Lancet 2010;376:667-9. [Ref.ID 89244]
25. Cita con resumen
Drazen JM, Wood AJJ. Don't mess with the DSMB. N Engl J Med 2010;363:477-8. [Ref.ID 88936]
26.Tiene citas relacionadas Cita con resumen
McCabe C, Chilcott J, Claxton K, Tappenden P, Cooper C, Roberts J, Cooper N, Abrams K. Continuing the scheme is unjustified. BMJ 2010;340:1285,1287-1288. [Ref.ID 88681]
27.Tiene citas relacionadas Cita con resumen
Raftery J. Costly failure of a risk sharing scheme. BMJ 2010;340:1282-4. [Ref.ID 88680]
28.Tiene citas relacionadas Cita con resumen
Scolding N. The multiple sclerosis risk sharing scheme. BMJ 2010;340:1255-6. [Ref.ID 88672]
29. Cita con resumen
Moynihan R. US drug manufacturers will have to disclose payments to doctors. BMJ 2010;340:671. [Ref.ID 88184]
30. Cita con resumen
McCartney M. Generic drugs: protest group was not quite what it seemed. BMJ 2010;340:627. [Ref.ID 88141]
32. Cita con resumen
Law MR, Soumerai SB, Adams AS, Majumdar SR. Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Arch Intern Med 2009;169:1969-74. [Ref.ID 87122]
33. Cita con resumen
Chalmers I. Explaining the unbiased creation of treatment comparison groups. Lancet 2009;374:1670-1. [Ref.ID 87078]
35. Cita con resumen
Kmietowicz Z. Patients and doctors are asked to report antivirals' side effects. BMJ 2009;339:66. [Ref.ID 86235]
37. Cita con resumen
Shimmings A. Public Citizen calls for a halt to prasugrel review. Scrip 2009;3449:10. [Ref.ID 86069]
38. Cita con resumen
Moynihan R. Canadian company demands right to publish drug adverts. BMJ 2009;338:1164. [Ref.ID 85890]
39. Cita con resumen
Faigen N. US advocacy group urges ban on all commercial CME. Scrip 2009;3436:35. [Ref.ID 85495]
40. Cita con resumen
Bristol N. Medicare drug expansion causes controversy in the USA. Lancet 2009;373:532. [Ref.ID 85276]
Seleccionar todas
<< anterior 21 a 40 de 358 siguiente >>